by Nick Paul Taylor | Feb 27, 2017 7:34am Pharma Two B will run a phase 3 of its pramipexole-rasagiline fixed-dose combination P2B001. Pharma Two B has raised $30 million…
Medical device innovation doesn’t just come from small, single-product startups – contract manufacturers are increasingly a part of developing truly disruptive medtech. Chris Newmarker, Managing Editor People sometimes make the mistake…
Listen to Medtech Insight's podcast on selected Israeli medical device & digital health companies that was broadcast this week. On this week's Medtech Insight podcast: the response by a US…
Genetically engineered T-cells treat leukemia in babies February 16, 2017 By Danielle Kirsh Researchers in London have successfully treated leukemia in two babies, in what they are touting as the…
Hemonitor measures blood flow in the main artery of intensive care patients. The MindUP technology incubator, a partnership between Pitango Venture Capital, the Rambam Health Care Campus, medical device company…
Catherine Longworth@MedtechCate [email protected] Executive Summary An analytics platform developed by Israeli big data company Intensix has shown high accuracy for detecting and predicting sepsis in critical care. The positive results…
Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes…
Mammoth American multinationals depend on ingenuity from small Israeli startups to drive their businesses forward. By Abigail Klein Leichman FEBRUARY 20, 2017, 10:20 AM To understand the strong and…
by Nick Paul Taylor | Feb 21, 2017 9:45am VBL Therapeutics has presented more data from a phase 2 trial of VB-111 monotherapy in thyroid cancer patients. The release adds…
By Eliot Beer, 15-Feb-2017 Gut microbiome analysis firm DaylWo will collaborate with Johnson & Johnson on personalised clinical nutrition for diabetes, and plans to open up its nutrition recommendation platform…